Associated Papers
Optimized Anchor-Modified Peptides Targeting Mutated RAS Are Promising Candidates for Immunotherapy.
Baleeiro RB et al.
Frontiers in Immunology, 2022
Healthy Donors Harbor Memory T Cell Responses to RAS Neo-Antigens.
Holmström MO et al.
Cancers, 2020
Mutated RAS: Targeting the "Untargetable" with T Cells.
Chatani PD et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2020
Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanoma.
Carlino MS et al.
British Journal of Cancer, 2014
Select a paper to view details